|1.||Chang, Ming-Shi: 19 articles (01/2015 - 10/2002)|
|2.||Hsu, Yu-Hsiang: 9 articles (01/2015 - 09/2006)|
|3.||Chen, Wei-Yu: 7 articles (08/2011 - 10/2005)|
|4.||Hsing, Chung-Hsi: 6 articles (01/2015 - 06/2006)|
|5.||Wei, Chi-Chen: 5 articles (09/2014 - 10/2005)|
|6.||Sabat, Robert: 5 articles (07/2011 - 10/2007)|
|7.||Wolk, Kerstin: 5 articles (07/2011 - 10/2007)|
|8.||Michalak-Stoma, Anna: 4 articles (01/2015 - 01/2008)|
|9.||Volk, Hans-Dieter: 4 articles (01/2011 - 10/2007)|
|10.||Sterry, Wolfram: 4 articles (01/2011 - 10/2007)|
|1.||Psoriasis (Pustulosis Palmaris et Plantaris)
12/01/2004 - "Although association analysis of the IL-19 gene indicated that minor alleles of the IL-19 gene SNPs (rs2243188, rs2243169 and rs2243158) revealed protective effect to psoriasis and haplotype analysis of the IL-19 gene proved significant protective effect of the TGATA haplotype in case of late-onset disease, combined haplotype analysis of the IL-19 and -20 genes demonstrated that protective effect of the IL-19 gene is secondary to the susceptibility effect of the IL-20 gene."
05/01/2014 - "Our study supports that IL-20 is involved in the pathogenesis of psoriasis. "
02/01/2009 - "In this study, we investigate the effects both of blocking IL-20 signalling in psoriatic plaques and of adding IL-20 to nonlesional psoriasis skin. "
08/01/2005 - "Performing a comprehensive analysis using the data regarding SNPs of IL-24 gene together with the previously published data regarding IL-19 and IL-20 SNPs, we identified two haplotype blocks within the region q32 of chromosome 1. The main result of the present study is that while the IL-19/IL-20 extended haplotype CACCGGAA is a significant susceptibility factor for psoriasis (previous study), IL-20/IL-24 haplotypes CAAAC, TGGGT and CGAGT have a significant protective effect. "
11/01/2015 - "IL-20 is involved in the development of skin psoriasis. "
09/01/2006 - "The rat CIA model demonstrated that IL-20 was involved in the pathogenesis of arthritis, because sIL-20RI significantly reduced arthritis in rats with CIA. "
09/01/2006 - "Thus, IL-20 may modulate the incidence and severity of arthritis and play important roles at local sites of inflammation."
11/01/2010 - "In vivo, treatment with 7E alone or in combination with etanercept significantly reduced the severity of arthritis by decreasing the hind paw thickness and swelling, preventing cartilage damage and bone loss, and reducing the expression of IL-20, IL-1β, IL-6, RANKL, and matrix metalloproteinases (MMPs) in synovial tissue. "
|3.||Liver Cirrhosis (Hepatic Cirrhosis)
09/01/2014 - "We identified a pivotal role of IL-20 in liver injury and showed that 7E and 51D may be therapeutic for liver fibrosis."
09/01/2014 - "We explored the involvement of IL-20 in liver injury and the therapeutic potential of IL-20 antagonists for treating liver fibrosis. "
09/01/2014 - "IL-20 and IL-20R1 antibodies protect against liver fibrosis."
07/01/2014 - "Reduction of IL-20 Expression in Rheumatoid Arthritis by Linear Polarized Infrared Light Irradiation."
01/01/2008 - "Both IL-20 and IL-24 showed correlations to CCL2/MCP-1 in plasma from rheumatoid arthritis and spondyloarthropathy patients. "
01/01/2008 - "The expression of IL-20 and IL-24 and their shared receptors are increased in rheumatoid arthritis and spondyloarthropathy."
01/01/2015 - "IL-20 protein levels were significantly higher in synovial fluid samples from patients with rheumatoid arthritis compared to osteoarthritis (p < 0.001), while serum levels of IL-20 did not differ between patients with rheumatoid arthritis, osteoarthritis or healthy controls. "
01/01/2008 - "IL-20 was increased in plasma of rheumatoid arthritis patients compared with osteoarthritis patients and IL-24 was increased in synovial fluid and plasma of rheumatoid arthritis and spondyloarthropathy patients compared with osteoarthritis patients. "
02/01/2014 - "This study demonstrates that rs1713239 and infection may have potential synergetic effect on modulating the transcriptional activity of IL-20. "
08/01/2013 - "Our findings identify an immunosuppressive role for IL-19, IL-20 and IL-24 during infection that could be therapeutically targeted to alter susceptibility to infection. "
04/01/2006 - "The effect of IL-19 and IL-20 in pregnancy will be dependent on their concentrations and other environmental factors such as infection."
11/04/2004 - "The regulatory mechanisms leading to IL-20 expression during infection have not been elucidated. "
|1.||Interleukin-6 (Interleukin 6)
|3.||TNFR-Fc fusion protein (etanercept)
|6.||Interleukin-10 (Interleukin 10)
|7.||Interleukin-17 (Interleukin 27)
|9.||interleukin 20 (IL-20)
|10.||Interleukin-23 (Interleukin 23)
|3.||Heterologous Transplantation (Xenotransplantation)
|4.||Transplantation (Transplant Recipients)